Your Health Plan:
Your Health Plan:
Not SelectedHADLIMA (adalimumab) is a biosimilar prescription drug for treatment of Rheumatoid Arthritis, Juvenile arthritis, Juvenile polyarthritis, Arthritis, Psoriatic, Ankylosing spondylitis, Crohn Disease, Ulcerative Colitis, Psoriasis, Hidradenitis Suppurativa, Uveitis and Panuveitis. HADLIMA is a tumor necrosis factor blocker. It is available in the form of subcutaneous solution.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $1192-1202.
Patient Assistance Prorgams are found:
Other alternatives to HADLIMA may include:
